(NASDAQ: ACB) Aurora Cannabis's forecast annual revenue growth rate of 9.34% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.24%.
Aurora Cannabis's revenue in 2025 is $250,578,832.On average, 3 Wall Street analysts forecast ACB's revenue for 2026 to be $15,303,752,327, with the lowest ACB revenue forecast at $14,687,818,795, and the highest ACB revenue forecast at $16,223,575,644. On average, 1 Wall Street analysts forecast ACB's revenue for 2027 to be $16,668,950,753, with the lowest ACB revenue forecast at $16,668,950,753, and the highest ACB revenue forecast at $16,668,950,753.
In 2028, ACB is forecast to generate $18,508,372,449 in revenue, with the lowest revenue forecast at $18,508,372,449 and the highest revenue forecast at $18,508,372,449.